Gluck OS[au] - Search Results

Year	Number of Results
1981	1
1984	1
1985	1
1995	1
1997	1
1999	1
2000	2
2004	2
2005	3
2022	0

1

Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus.

Petri MA, Mease PJ, Merrill JT, Lahita RG, Iannini MJ, Yocum DE, Ginzler EM, Katz RS, Gluck OS, Genovese MC, Van Vollenhoven R, Kalunian KC, Manzi S, Greenwald MW, Buyon JP, Olsen NJ, Schiff MH, Kavanaugh AF, Caldwell JR, Ramsey-Goldman R, St Clair EW, Goldman AL, Egan RM, Polisson RP, Moder KG, Rothfield NF, Spencer RT, Hobbs K, Fessler BJ, Calabrese LH, Moreland LW, Cohen SB, Quarles BJ, Strand V, Gurwith M, Schwartz KE. Petri MA, et al. Among authors: gluck os. Arthritis Rheum. 2004 Sep;50(9):2858-68. doi: 10.1002/art.20427. Arthritis Rheum. 2004. PMID: 15452837 Free article. Clinical Trial.

2

Antipolymer antibody reactivity in a subset of patients with fibromyalgia correlates with severity.

Wilson RB, Gluck OS, Tesser JR, Rice JC, Meyer A, Bridges AJ. Wilson RB, et al. Among authors: gluck os. J Rheumatol. 1999 Feb;26(2):402-7. J Rheumatol. 1999. PMID: 9972976

3

Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases.

Dykman TR, Gluck OS, Murphy WA, Hahn TJ, Hahn BH. Dykman TR, et al. Among authors: gluck os. Arthritis Rheum. 1985 Apr;28(4):361-8. doi: 10.1002/art.1780280402. Arthritis Rheum. 1985. PMID: 3872664

4

Effects of prasterone on bone mineral density in women with systemic lupus erythematosus receiving chronic glucocorticoid therapy.

Mease PJ, Ginzler EM, Gluck OS, Schiff M, Goldman A, Greenwald M, Cohen S, Egan R, Quarles BJ, Schwartz KE. Mease PJ, et al. Among authors: gluck os. J Rheumatol. 2005 Apr;32(4):616-21. J Rheumatol. 2005. PMID: 15801015 Clinical Trial.

5

Use of antipolymer antibody assay in recipients of silicone breast implants.

Tenenbaum SA, Rice JC, Espinoza LR, Cuéllar ML, Plymale DR, Sander DM, Williamson LL, Haislip AM, Gluck OS, Tesser JR. Tenenbaum SA, et al. Among authors: gluck os. Lancet. 1997 Feb 15;349(9050):449-54. doi: 10.1016/s0140-6736(96)07131-0. Lancet. 1997. PMID: 9040573

6

Effect of oral 1,25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases.

Dykman TR, Haralson KM, Gluck OS, Murphy WA, Teitelbaum SL, Hahn TJ, Hahn BH. Dykman TR, et al. Among authors: gluck os. Arthritis Rheum. 1984 Dec;27(12):1336-43. doi: 10.1002/art.1780271203. Arthritis Rheum. 1984. PMID: 6334524

7

Oral hormone therapy with 17beta-estradiol and 17beta-estradiol in combination with norethindrone acetate in the prevention of bone loss in early postmenopausal women: dose-dependent effects.

Greenwald MW, Gluck OS, Lang E, Rakov V. Greenwald MW, et al. Among authors: gluck os. Menopause. 2005 Nov-Dec;12(6):741-8. doi: 10.1097/01.gme.0000184425.73567.12. Epub 2005 Nov 8. Menopause. 2005. PMID: 16278618 Clinical Trial.

8

A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis.

Bradley JD, Dmitrienko AA, Kivitz AJ, Gluck OS, Weaver AL, Wiesenhutter C, Myers SL, Sides GD. Bradley JD, et al. Among authors: gluck os. J Rheumatol. 2005 Mar;32(3):417-23. J Rheumatol. 2005. PMID: 15742431 Clinical Trial.

9

Bone loss in adults receiving alternate day glucocorticoid therapy. A comparison with daily therapy.

Gluck OS, Murphy WA, Hahn TJ, Hahn B. Gluck OS, et al. Arthritis Rheum. 1981 Jul;24(7):892-8. doi: 10.1002/art.1780240705. Arthritis Rheum. 1981. PMID: 7259801

10

Involutional lipoatrophy: macrophage-related involution of fat lobules.

Zalla MJ, Winkelmann RK, Gluck OS. Zalla MJ, et al. Among authors: gluck os. Dermatology. 1995;191(2):149-53. doi: 10.1159/000246535. Dermatology. 1995. PMID: 8520064

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results